GHK-Cu vs Thymalin
A neutral, side-by-side comparison of two anti-aging & longevity peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
GHK-Cu
GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It plays a role in wound healing, skin regeneration, and anti-inflammatory signaling. Levels decline significantly with age, which has driven interest in topical and injectable supplementation.
Full profileThymalin
Thymus-derived peptide bioregulator developed in Russia containing a mixture of low-molecular-weight peptides extracted from calf thymus. Primarily studied for reversing immunological aging (immunosenescence) and extending healthy lifespan. Vladimir Khavinson's longitudinal research on elderly patients links thymalin administration to significant improvements in immune markers and all-cause mortality reduction.
Full profile| GHK-Cu | Thymalin | |
|---|---|---|
| Category | Anti-Aging & Longevity | Anti-Aging & Longevity |
| Also known as | Copper Peptide GHK-Cu, Glycyl-L-histidyl-L-lysine copper, Copper Tripeptide-1 | thymic peptide bioregulator, T-activin extract, thymus peptide, thymic bioregulator |
| Evidence | Research-stage | Research-stage |
| Dosing range | 1mg–3mg mg, daily to every other day (injectable); twice daily (topical) | 5mg–20mg mg, 5–10 day course, 1–2x per year |
| Administration | Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics) | Intramuscular injection, Subcutaneous injection |
| Key side effects | Injection site redness (transient), Mild skin irritation with topical (typically resolves with reduced frequency), Rarely reported: metallic taste (with injectable use at higher doses) | Injection site reactions, Mild fever (rare), Temporary increase in immune activity (desired response), Rare hypersensitivity |
| Cited sources | 4 references | 2 references |
Key differences
- Administration: GHK-Cu — Subcutaneous injection, Topical application (cream, serum — most common consumer use), Intradermal injection (skincare clinics); Thymalin — Intramuscular injection, Subcutaneous injection.
- Frequency: GHK-Cu is typically daily to every other day (injectable); twice daily (topical); Thymalin is 5–10 day course, 1–2x per year.
- Research depth: this profile cites 4 sources for GHK-Cu vs 2 for Thymalin.
How each works
GHK-Cu
GHK-Cu has been studied for its ability to stimulate collagen, elastin, and glycosaminoglycan synthesis, promote wound healing, and exhibit antioxidant and anti-inflammatory effects. Gene-expression work by Pickart and colleagues found GHK altered expression (>50% up or down) in roughly 32% of assayed human genes — the basis of the widely-cited '~4,000 genes' figure. Its evidence is strongest for in-vitro and topical/cosmetic use; robust human trials of injectable/systemic GHK-Cu are lacking.
Thymalin
Thymalin contains multiple bioactive peptides that stimulate T-lymphocyte differentiation and restore thymic function that declines with age. In Khavinson's 6-year controlled trial of elderly patients (78–89 years), annual thymalin courses were associated with significantly lower mortality and improved immune parameters vs. controls. Proposed mechanisms include telomerase activation in immune cells and restoration of thymic epithelial cell function.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.